Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine for Phobia of Heights
NCT01037101Phase 2Terminated
- Sponsor
- CAMC Health System
- Start
- Jul 2009
- Primary completion
- Feb 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-cycloserine in acrophobia, sponsored by CAMC Health System. Started Jul 2009; status: terminated.
02
Drugs
d-cycloserine
03
Conditions
acrophobia
Beyond the preview
Go deeper on NCT01037101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01037101.